tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Praxis Precision price target raised to $115 from $105 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Praxis Precision (PRAX) to $115 from $105 and keeps a Buy rating on the shares. The firm says the RADIANT trial data showcased vormatrigine’s “best-in-disease” efficacy in highly refractory focal onset seizure.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1